Unknown

Dataset Information

A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections.


ABSTRACT:

Background

Biologic agents are emerging as an important treatment option for immune-mediated diseases. Injection site reactions following subcutaneous injection of biologic agents is not well described in the literature.

Objective

To summarize injection site reaction data in phase 3 trials of all biologic agents.

Methods

MEDLINE, Embase, and CENTRAL databases were systematically searched on February 8, 2022. Proportional meta-analysis was conducted to summarize injection site reaction prevalence for each biologic.

Results

There were 158 articles included in the review. The most common types of injection site reactions were erythema (42.8%), unspecified reaction (23.3%), pain (12.4%), and pruritus (5.7%). No patients discontinued their treatment due to injection

SUBMITTER: Kim PJ 

PROVIDER: S-EPMC10486173 | biostudies-literature | 2023 Jul-Aug

REPOSITORIES: biostudies-literature